Purple Biotech (PPBT) Pension (2015 - 2026)
Purple Biotech's (PPBT) quarterly Pension came in at $170000.0 in Q2 2026, up 21.43% year-over-year from $140000.0 in Q2 2025, and up 6.25% quarter-over-quarter from $160000.0 in Q1 2026.
Analysis
Purple Biotech (PPBT) Pension (2015 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Pension for 12 consecutive years, with $170000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Pension rose 21.43% year-over-year to $170000.0 in Q2 2026; TTM through Jun 2026 was $170000.0, a 21.43% increase from a year earlier, with the FY2025 full-year figure at $160000.0, up 14.29% from the prior year.
- Pension was $170000.0 for Q2 2026 at Purple Biotech, up from $160000.0 in the prior quarter.
- Over five years, Pension peaked at $292000.0 in Q1 2022 and troughed at $140000.0 in Q4 2024.
- A 5-year average of $161666.7 and a median of $141000.0 in 2023 frame the typical range for Pension.
- Across the five-year window, Pension sank 51.71% in 2023 and grew 21.43% in 2026, its largest moves.
- Over 5 years, Pension stood at $145000.0 in 2022, then dropped by 2.76% to $141000.0 in 2023, then fell by 0.71% to $140000.0 in 2024, then climbed by 14.29% to $160000.0 in 2025, then rose by 6.25% to $170000.0 in 2026.
- The last three Pension figures came in at $170000.0 (Q2 2026), $160000.0 (Q1 2026), and $160000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.24 Bn | 192.25 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.01 Bn | 176.83 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.33 Bn | 123.47 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.87 Bn | 73.87 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.27 Bn | 55.08 Bn | 1.37 Bn |
| 6 | Moderna | 53.93 Bn | 48.79 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.17 Bn | 29.86 Bn | 992.69 Mn |
| 8 | Biogen | 31.89 Bn | 30.60 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn |
| 10 | Purple Biotech | 282,022.44 | 282,022.44 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 170,000.00 |
| Mar 31, 2026 | 160,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 141,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 141,000.00 |
| Sep 30, 2023 | 141,000.00 |
| Jun 30, 2023 | 141,000.00 |
| Mar 31, 2023 | 141,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Sep 30, 2022 | 144,000.00 |
| Jun 30, 2022 | 292,000.00 |
| Mar 31, 2022 | 292,000.00 |
| Dec 31, 2021 | 292,000.00 |
| Sep 30, 2021 | 265,000.00 |